Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease.
about
Bacterial Communities: Interactions to ScaleNon-Antibiotic Prophylaxis for Urinary Tract InfectionsResurrecting the intestinal microbiota to combat antibiotic-resistant pathogensThe potential impact of coinfection on antimicrobial chemotherapy and drug resistanceFecal Microbiota Transplantation: Expanding Horizons for Clostridium difficile Infections and BeyondGut microbiome and kidney disease: a bidirectional relationship.Fecal Microbiota Transfer for Multidrug-Resistant Gram-Negatives: A Clinical Success Combined With Microbiological FailureImpact of fluoroquinolones on human microbiota. Focus on the emergence of antibiotic resistance.Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.Understanding Luminal Microorganisms and Their Potential Effectiveness in Treating Intestinal InflammationThe Microbiome, Systemic Immune Function, and Allotransplantation.Fecal Microbial Transplants Reduce Antibiotic-resistant Genes in Patients With Recurrent Clostridium difficile Infection.Clearance of Vancomycin-Resistant Enterococcus Concomitant With Administration of a Microbiota-Based Drug Targeted at Recurrent Clostridium difficile InfectionTHE POWER OF POOP: FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIUM DIFFICILE INFECTION.Prolonged colonisation with Escherichia coli O25:ST131 versus other extended-spectrum beta-lactamase-producing E. coli in a long-term care facility with high endemic level of rectal colonisation, the Netherlands, 2013 to 2014.Microbial approaches for targeting antibiotic-resistant bacteria.Mouse model of colonization of the digestive tract with Acinetobacter baumannii and subsequent pneumonia.Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.Fecal microbiota transplantation for the intestinal decolonization of extensively antimicrobial-resistant opportunistic pathogens: a review.Novel Indications for Fecal Microbial Transplantation: Update and Review of the Literature.[Fecal microbiota transplantation: indications and perspectives].Fecal microbiota transplantation and successful resolution of multidrug-resistant-organism colonization.Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection.Editorial Commentary: Fecal ESBL Screening: Are We Ready for This Information?Fecal Microbiota Transplantation Inhibits Multidrug-Resistant Gut Pathogens: Preliminary Report Performed in an Immunocompromised Host.Editorial Commentary: The Dawning of Microbiome Remediation for Addressing Antibiotic Resistance.Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series.Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections.Effect of faecal microbiota transplantation on mouse gut colonization with carbapenemase-producing Escherichia coli.The Gut-Kidney Axis: Putative Interconnections Between Gastrointestinal and Renal Disorders
P2860
Q26739810-784814BF-D08B-4DAF-B3DA-3103E08E8BB7Q26752350-574781C2-79FF-4F76-A4F8-BBD5D812907FQ28075653-02ED856C-B389-4DF1-A29B-85A54C675E70Q28081282-7C706132-9B8F-4CF0-A73B-3BC69A7AD5EEQ28084737-F26C1AC9-29C9-4EA0-8429-9E130D1E8B12Q33586234-1776EC5A-2DEE-4B76-BE89-83EA5D3DCD46Q33609466-C8C5F4A5-BFA0-4994-B39A-78E02623D182Q35676675-C3CB66FF-3DFF-4E1A-A5D0-E4B5A369A6F2Q35790385-063C5C8B-7F36-443C-B2FF-5C6EF274AD9AQ35803240-F6A88A1A-4FA7-4948-88E3-1B35195FE3E5Q35866187-5D28087F-5537-4073-83F9-AE92D4A46C9BQ35973224-42F346A9-53FB-4D76-A8BD-702890566B02Q37305507-60F6FD6E-9DF5-4271-89E9-C3F52B5F0FCAQ37563802-4533A896-A200-4980-A1D2-03703E3C55B5Q37623615-C5890879-1A46-4E14-B38B-E36BA7237DA0Q38644054-72FC7C7A-0AA6-4122-A881-0CA5164DACCAQ38679502-35C9B6C0-0854-4889-A91B-81BCAD68128CQ38740977-5FC9E264-4188-4A33-8FB5-1F1C8F47AFD7Q38838013-DD097370-8993-4E03-AFF8-D37F0996C4B2Q39185571-6A5D2764-4940-49BC-91BD-CECAADA8C17CQ40397907-878117EB-604E-4EC8-A495-725515391EBBQ40672307-143A68AA-4F93-4F3C-B2C2-723B9DE95973Q41996759-331D2A36-A027-45CB-9E47-B92BBF0DB648Q42418846-7F0DC4D5-63E3-4EFA-8C36-89A97BA8C862Q42796168-4EB89264-234D-485E-AE18-E6D81DF9F817Q46572123-16CBF83B-9133-4BCE-AC2E-F48FC969CB03Q47112915-D0B91D16-DC76-4906-8CF1-84DEF90C4C20Q49486829-3053FE38-2C48-4200-B053-1CF1C236E2FEQ53746799-AFB40811-9445-47B1-9AF5-724DE33CBC11Q57072601-0EC4CBE7-1083-4390-BCEE-ADB157C90247
P2860
Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Donor feces infusion for eradi ...... with end stage renal disease.
@en
Donor feces infusion for eradi ...... with end stage renal disease.
@nl
type
label
Donor feces infusion for eradi ...... with end stage renal disease.
@en
Donor feces infusion for eradi ...... with end stage renal disease.
@nl
prefLabel
Donor feces infusion for eradi ...... with end stage renal disease.
@en
Donor feces infusion for eradi ...... with end stage renal disease.
@nl
P2093
P921
P356
P1476
Donor feces infusion for eradi ...... with end stage renal disease.
@en
P2093
E van Nood
F J Bemelman
I J M ten Berge
M Nieuwdorp
S E Geerlings
P304
P356
10.1111/1469-0691.12683
P577
2014-07-08T00:00:00Z